Breaking News
January 20, 2018 - MSU scientists seek to identify brain mechanisms related to psychosis
January 20, 2018 - Syndax Pharmaceuticals Announces Clinical Collaboration to Evaluate Entinostat in Combination with anti-PD-L1 Cancer Immunotherapy in Breast Cancer
January 20, 2018 - Endoscopes Over Microscopes in Retinal Surgery: Ophthalmology Times
January 20, 2018 - Technology not taking over children’s lives despite screen-time increase
January 20, 2018 - Study finds extensive contamination around lead battery recycling plants in 7 African countries
January 20, 2018 - Flu may pass to others through exhaled breath, study shows
January 20, 2018 - Neuronal loss very limited in Alzheimer’s disease, new study shows
January 20, 2018 - Novel robot can aid treatment of rare birth defect
January 19, 2018 - TherapeuticsMD Announces Submission of New Drug Application for TX-001HR
January 19, 2018 - Fighting Infant Mortality | Medpage Today
January 19, 2018 - Researchers offer new evidence on four-year-old children’s knowledge about ecology
January 19, 2018 - Analysis finds overlooked crucial factor in determining prognosis for DIPGs
January 19, 2018 - Review explores consequences of genetic testing and cancer risk-reducing surgery
January 19, 2018 - Morning Break: HHS Div. of Religious Freedom; Trump’s Heart Health; Minister of Loneliness
January 19, 2018 - Parkinson’s disease ‘jerking’ side effect detected by algorithm
January 19, 2018 - New analysis finds dramatic increases in maternal mortality rates
January 19, 2018 - Weight-Loss Surgery’s Benefits Wane Over Time for Diabetics
January 19, 2018 - Cath Lab Recap: Sapien 3 Delivery System Recall; Transatlantic PCI Smackdown
January 19, 2018 - Parkinson’s treatment could be more effective, student finds
January 19, 2018 - New vaccine approach offers effective protection against tuberculosis
January 19, 2018 - Home care agencies often wrongly deny Medicare help to the chronically ill
January 19, 2018 - One hundred percent fruit juice does not alter blood sugar levels
January 19, 2018 - Prebiotics could enhance learning and memory skills in infants
January 19, 2018 - CMS May Cover MRI With Cardiac Devices Across the Board
January 19, 2018 - As income rises, women get slimmer—but not men
January 19, 2018 - Researchers develop adhesive materials to prevent bracket stains on teeth
January 19, 2018 - Flu can be spread without coughs and sneezes
January 19, 2018 - AMSBIO’s new recombinant protein shows great promise for organoid culture
January 19, 2018 - AbbVie’s Upadacitinib Granted Breakthrough Therapy Designation from the U.S. Food and Drug Administration for Atopic Dermatitis
January 19, 2018 - ASH: Pomalidomide Dose Escalation Improves Response
January 19, 2018 - Is your child’s school an obesity risk?
January 19, 2018 - Scientists describe groundbreaking training effect on the innate immune system
January 19, 2018 - MAST announces new AmpC, ESBL & Carbapenemase Detection Set
January 19, 2018 - Signaling molecules likely involved in concussions, rodent studies show
January 19, 2018 - Mast introduces Carba plus for CPE and OXA-48 confirmation
January 19, 2018 - Paleolithic diet helps overweight women maintain weight loss
January 19, 2018 - Agios Submits New Drug Application to the FDA for Ivosidenib for the Treatment of Patients with Relapsed/Refractory AML and an IDH1 Mutation
January 19, 2018 - This Flu Season, Don’t Forget About Tamiflu
January 19, 2018 - Amsterdam wins battle to host EU medicines agency after Brexit
January 19, 2018 - Study suggests movement as accurate method to diagnose neurodevelopmental disorders
January 19, 2018 - Maximize resolution in deep imaging for neuroscience research with Olympus TruResolution objectives
January 19, 2018 - Bilingualism may benefit children with ASD
January 19, 2018 - FDA Alert: Levofloxacin in 5 Percent Dextrose 250mg/50mL by AuroMedics: Recall
January 19, 2018 - USPSTF Not Backing Ankle-Brachial Index, CRP, or Coronary Calcium
January 19, 2018 - Higher omega-3 fatty acid intake tied to lower glaucoma risk
January 19, 2018 - Findings reveal conventional cancer therapy as double-edged sword
January 19, 2018 - Health Highlights: Jan. 16, 2018
January 19, 2018 - Morning Break: Anti-Emetic Warning; Uninsured Rate Jumps; Flu Worsens Saline Shortage
January 19, 2018 - Increased use of ambulatory surgery centers for cataract surgery
January 19, 2018 - Not-for-profit hospitals coming up with their own generic medicines to combat shortages
January 19, 2018 - $500 cancer detection blood tests may soon become reality
January 19, 2018 - Chronic traumatic encephalopathy may start early even without signs of concussions
January 19, 2018 - Warm-up program for children cuts soccer injuries by 50%
January 19, 2018 - ‘You’re Old and You Need Tests’: What We Heard This Week
January 19, 2018 - Egg-preserving hysterectomy raises heart risks later: study
January 19, 2018 - GA-map Dysbiosis Test identifies IBS patients who respond to FODMAP diet, study shows
January 19, 2018 - Study explores mortality and health-related habits in former elite athletes and their brothers
January 19, 2018 - New biodegradable sensors could assist doctors
January 19, 2018 - Modular gene enhancers may be suitable target in treatment of blood cancer
January 18, 2018 - New precision medicine trial for metastatic pancreatic cancer
January 18, 2018 - Shire Receives FDA Breakthrough Therapy Designation for Maribavir, an Investigational Treatment for Cytomegalovirus (CMV) Infection in Transplant Patients
January 18, 2018 - Pre-Existing Patient-Valve Mismatch Trips Up ViV Implant
January 18, 2018 - Adolescents: health risks and solutions
January 18, 2018 - US woman delivers baby from embryo frozen for 24 years
January 18, 2018 - Study identifies new target for treatment of depression
January 18, 2018 - LJI study reveals key player that promotes skin inflammation in atopic dermatitis
January 18, 2018 - Study devises efficient and economical strategy to screen breast and ovarian cancer gene mutations
January 18, 2018 - Agile Therapeutics, Inc. Receives a Complete Response Letter from the FDA for Twirla (AG200-15) for the Prevention of Pregnancy
January 18, 2018 - Gene Therapy for Inherited Retinal Dystrophy Gets FDA Clearance
January 18, 2018 - Researchers identify a new chemical pathway that helps the brain detect sweet, savory and bitter flavors
January 18, 2018 - IBV develops platform that helps companies to diagnose wellbeing of their workforce
January 18, 2018 - Study to test new precision medicine approach for metastatic pancreatic cancer
January 18, 2018 - World’s first vaccine relieves grass pollen allergy symptoms by at least 25%, study shows
January 18, 2018 - FDA Approves New Indication for Gilotrif (afatinib) in EGFR Mutation-Positive NSCLC
January 18, 2018 - Oncologists Dish on Top Issues for 2018
January 18, 2018 - Researchers identify new potential drug target for Huntington’s disease
January 18, 2018 - Metrohm USA welcomes employees to new headquarters in Florida
January 18, 2018 - Human waste remains main source of fecal pollution in the river Danube
January 18, 2018 - Expert discusses how to stay healthy during flu season
January 18, 2018 - New biomaterials-based system improves T-cell production
Using Machine Learning to Accurately Diagnose Childhood Autism Sooner

Using Machine Learning to Accurately Diagnose Childhood Autism Sooner

image_pdfDownload PDFimage_print

An interview with Dr Taraman, conducted by James Ives, MPsych

Please give an overview of autism diagnosis currently used in medical practice. What criteria and methods are used? How prevalent are autism diagnoses?

Autism is a clinical diagnosis. There is no one test to diagnose autism. Depending on the type of medical professional diagnosing, typically the DSM-V (standard classification of mental disorders used by mental health professionals in the U.S.) is used to diagnose by primary care physicians, neurologists, and psychiatrists.

Additionally, a set of questions known as the ADI-R (Autism Diagnostic Interview-Revised) and observations in a semi-structured assessment known as the ADOS (Autism Diagnostic Observation Schedule) are typically used by developmental pediatricians.

The most recent numbers show the prevalence of autism at 1 in 68 people. It is higher in males at 1 in 42 while at 1 in 189 in females. Despite this relatively frequent condition, many physicians are uncomfortable diagnosing and managing the symptoms of autism.

Are there other methods that could be used to diagnose autism? Are there genetic tests available?

There are currently laboratory or imaging tests that diagnose ASD. There are an increasing number of genetic mutations that are being linked to autism; copy number variations, for example, which occur more commonly in advanced paternal age.

Patients of genetic conditions such as Rett Syndrome typically exhibit autistic behaviors and meet the criteria for autism. Unfortunately, we don’t fully understand the genetics of autism at this time, however, it is well established that genetic risk factors exist. The risk for a sibling of a child with autism is estimated to be as high as 1 in 5.

At what age are children diagnosed with autism? Could this condition be diagnosed sooner? What holds back accurate diagnoses?

The average age of diagnosis in the US is 4 years, which is unacceptable. Parents often report concerns starting around 12 months old. There continues to be a “watchful waiting” that occurs and then many patients are referred to a specialist for evaluation and diagnosis, however, due to shortages of these specialists especially in rural areas, long appointment wait times and waitlists are very common.

The reason that this delay is so tragic is that there is a very limited window of opportunity in which therapy is most effective. In this early intervention time frame, it has been shown that intensive therapies such as speech and behavioral therapy can later help children with autism transition out of special education classrooms into mainstream education and in some cases with higher functioning patients actually lose the diagnosis and effectively be “cured”.

I have so many personal experiences with this where early diagnosis and intervention have made significant impact for my patients diagnosed with autism and conversely, despite best efforts a later diagnosis and initiation of treatment much less effective.

There are many barriers that hold back an early diagnosis, such as:

  • Primary care physicians often do not get adequate training in neurological disorders during residency.
  • The diagnosis relies on the recognition of a range of behavioral symptoms that vary greatly from case to case.
  • Diagnosis is even more difficult the younger the child is during development, as there is a greater variability the younger the child.
  • Autism overlaps with other childhood neuropsychiatric disorders.
  • The ADI-R and ADOS are time intensive and require specialized training.

Please give an overview of Cognoa, the machine learning aspects of the platform and the role that it can play in autism diagnosis.

Dr. Dennis Wall, PhD while at Harvard University initially used machine learning techniques to create an algorithm to determine which questions typically used to evaluate children for autism were most predictive.

Later, he built upon this work using home videos provided by parents to observe behaviors that were indicative of autism. The team at Cognoa of which he is a co-founder, has expanded on this research to create an advanced algorithm that can empower primary care physicians to make the diagnosis of autism.

This can significantly reduce the age of diagnosis and in one study, Cognoa correctly identified autism with an average age of 3.08 years old, 13 months sooner than the national average. In analyzing the results from a recent multi-center clinical trial, Cognoa could reduce the number of children that are referred to specialists for autism evaluations by 70%.

Artificial Intelligence has the potential to enhance clinicians’ abilities and I am confident that it will significantly remove barriers and challenges surrounding the diagnosis of autism in the primary care setting.

On what data was the machine learning algorithm modelled? What research supports this program?

The Wall Lab initially used data from Autism Speaks’ Autism Genetic Resource Exchange (AGRE) to create the classifier and then used this same database, in addition to two independent sources (a collection of 1654 autistic individuals from the Simons Foundation and a collection of 322 autistic individuals from the Boston Autism Consortium) to show a high level of statistical accuracy in correctly classifying children with ASD.

Subsequently, Cognoa has continued to work closely with Dr. Wall to advance the algorithm. This improved algorithm was validated through a clinical study conducted at the Thompson Center, Vanderbilt, and the Medical University of South Carolina on over 400 children.

What are the limits to this machine learning approach? How likely is a false positive or a tendency to over diagnose autism?

One of the great things about machine learning is the ability to fine tune the algorithm to take into account real-world prevalence. Meaning that Cognoa is able to provide a different output for children in a primary care practice where the prevalence is 1:68 versus with specialists where the prevalence is closer to 1:30.

We have also built in a safety mechanism that allows the algorithm to say, “I don’t know”. This helps to make sure that when Cognoa flags a child with autism or not, it is as accurate as possible. For those children which Cognoa is not sure if they have autism, they would be referred to a specialist for evaluation.

What does the future hold for the Cognoa platform?

At Cognoa, we are focused on fundamentally changing the standard care for diagnosing and treating behavioral health conditions. Cognoa’s initial product, an assessment for child behavioral development, has been used by 300,000 families and validated in multiple clinical studies and we are actively working to increase both the depth of care we can provide to patients and doctors, as well as the breadth of behavioral health indications we can address.

We engage with clinicians and the FDA to develop diagnostic tools that are integrated with personalized behavioral intervention therapies that parents and doctors can use to ensure that children with delays receive the most effective treatments years sooner than the current system. At the same time, we are expanding our AI and clinical development to increase the breadth of behavioral health conditions we can diagnose and treat.

What advancements in autism diagnosis would you like to see in the future?

I would like to see the average age of diagnosis decrease to around 18-24 months, when early intervention will have the greatest impact. I believe that with Cognoa, we will be able to facilitate accurate diagnosis as early as 12 months.

Where can readers find more information?

To learn more, you can email me directly at [email protected] or visit www.cognoa.com.

About Dr. Taraman

Sharief Taraman, MD, is the Assistant Division Chief of pediatric neurology and medical informaticist at CHOC Children’s Hospital in Orange County, CA. He is an Assistant Clinical Professor at the University of California, Irvine. He also serves as the Vice President of Medical at Cognoa, a digital health company revolutionizing how children with developmental delays are diagnosed and supported.

Tagged with:

About author

Related Articles